- Home
- MREO vs YSXT Comparison
MREO vs YSXT Comparison
Compare MREO & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | YSXT |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United Kingdom | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.3M | 41.4M |
| IPO Year | 2017 | 2023 |
Fundamental Metrics
Financial Performance| Metric | MREO | YSXT |
|---|---|---|
| Price | $0.28 | $1.31 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $1.97 | N/A |
| AVG Volume (30 Days) | ★ 624.0K | 6.2K |
| Earning Date | 11-17-2026 | 07-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.50 |
| 52 Week High | $2.37 | $3.14 |
Technical Indicators
Market Signals| Indicator | MREO | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 49.26 |
| Support Level | $0.27 | $1.21 |
| Resistance Level | $0.35 | $1.51 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 20.85 | 54.05 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.